Primary Care/Hospitalist
RSSArticles
-
Transdiagnostic Cognitive Behavioral Therapy in Young Patients
This Danish randomized clinical trial compares a new form of cognitive behavioral therapy delivered in a community setting to “treatment as usual” for children and teens with emotional problems and shows advantages in multiple arenas, including parent-reported changes in child distress and impairment.
-
Air Filters and Asthma
Asthmatic children showed improved small airway mechanics following indoor filtration of particulates (2.5 µm and greater) using high-efficiency particulate air filtration devices.
-
Loneliness and Type 2 Diabetes Incidence
Loneliness appears to be an independent risk factor for type 2 diabetes, although further research to identify the causal relationship between loneliness and type 2 diabetes development is needed.
-
2021 Update on Adult Vaccinations with a Focus on SARS-CoV-2/COVID-19
Vaccination in adults remains one of the most important means of preventing disease in vulnerable populations. Certain vaccines, such as influenza, tetanus/diphtheria/pertussis, and the new COVID-19 vaccine are recommended for all adults, while others are recommended in subsets of adults depending on age, comorbidities, and certain risk factors.
-
AAP Revises Guidelines to Improve Treatment of Children with Disabilities
Group says pediatricians can be advocates for this population, which is more likely to be subjected to abuse and neglect.
-
FDA Approves AI Tool to Help Detect Colon Cancer
Machine learning gives clinicians another tool while trying to detect troubling signs during routine screening.
-
Dasiglucagon Injection (Zegalogue)
Dasiglucagon should be prescribed to treat severe hypoglycemia in pediatric and adult patients (≥ age 6 years).
-
Herpes Zoster Vaccine: Effective but Underused
The adjuvanted recombinant herpes zoster vaccine is highly effective in practice, but it is vastly underused.
-
Antibiotics: Less Is Better, Sometimes
In England, and likely in many other areas of the world, antibiotics are given for longer than necessary. Excessively long durations of antibiotic use do not help patients and risk leading to more resistant infections.
-
Is Empagliflozin Safe in Combination with a Neprilysin Inhibitor for Heart Failure?
A prespecified subgroup analysis of heart failure patients with reduced ejection fraction who were on neprilysin inhibitors before empagliflozin was administered (vs. those not on neprilysin inhibitors) showed the reduction in mortality and hospital admissions for heart failure was not attenuated by concurrent neprilysin use.